Log in to save to my catalogue

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c99debbd58a4f338d0756a975e5bd57

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

About this item

Full title

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

Publisher

Lausanne: Frontiers Research Foundation

Journal title

Frontiers in molecular neuroscience, 2021-07, Vol.14, p.713031-713031

Language

English

Formats

Publication information

Publisher

Lausanne: Frontiers Research Foundation

More information

Scope and Contents

Contents

Frontotemporal dementia (FTD) is a neurodegenerative disease, leading to behavioral changes and language difficulties. Heterozygous loss-of-function mutations in
progranulin
(
GRN
) induce haploinsufficiency of the protein and are associated with up to one-third of all genetic FTD cases worldwide. While the loss of GRN is primarily asso...

Alternative Titles

Full title

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5c99debbd58a4f338d0756a975e5bd57

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c99debbd58a4f338d0756a975e5bd57

Other Identifiers

ISSN

1662-5099

E-ISSN

1662-5099

DOI

10.3389/fnmol.2021.713031

How to access this item